Sponsor:
VA Office of Research and Development
Code:
NCT04038502
Conditions
Metastatic Castrate Resistant Prostate Cancer
BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2
RAD51B, RAD51C, RAD51D, or RAD54L Mutations
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Olaparib
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by VA Office of Research and Development on 2024-09-19.